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The decision to accept or decline a liver allograft for a patient on the transplant waiting list is complex. We hypothesized
that surgeons are not accurate at predicting donor-specific risks. Surgeon members of the American Society of Transplant
Surgeons were invited to complete a survey in which they predicted the 3-year risk of graft failure for a 53-year-old man
with alcoholic cirrhosis and a Model for End-Stage Liver Disease score of 21 with a liver from (1) a 30-year-old local donor
with traumatic brain death or (2) a 64-year-old regional donor with brain death from a stroke. Complete responses were
obtained from 201 surgeons, whose self-reported case volume represents the majority of liver transplants in the United
States. The surgeon-predicted 3-year risk of graft failure varied widely (more than 10-fold). In scenario 1, 90% of the
respondents provided lower estimates of the graft failure risk than the literature-derived estimate of 21% (P<0.001). In sce-
nario 2, 96% of the responses were lower than the literature-derived estimate of 40% (P< 0.001). In conclusion, transplant
surgeons vary widely in their predictions of the donor-specific risk of graft failure, and they demonstrate a systematic bias
toward inaccurately low estimates of graft failure, particularly for higher risk organs. Liver Transpl 19:987-990, 2013.
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Deceased donor livers available for transplantation
vary widely in quality. Donor characteristics such as
age, cause of death, and ischemia time can make
the difference between a 20% rate of graft failure and
a 40% rate of graft failure within 3 years after
transplantation.1
Each time an organ is offered, the surgeon and the
potential recipient must decide whether to accept that
offer or wait in the hope that a better one will come
along. These decisions are high-risk ones; a recent
study revealed that 84% of patients who die on the
waiting list have previously declined at least 1 organ
offer.2 These decisions are also complex ones.
Surgeons must incorporate multiple donor factors,
recipient factors, and donor-recipient interactions as
well as the local magnitude of the organ shortage and
various technical and logistical concerns. Thus, it is
perhaps not surprising that decisions about organ
quality vary widely by transplant center and are
susceptible to cognitive biases and external forces
such as policy changes and competition between
centers.3-5
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For these reasons, we hypothesized that surgeons
are not accurate at predicting donor-specific risks. We
performed a nationwide survey to test this hypothesis.
MATERIALS AND METHODS
Survey Design
Surgeon members of the American Society of Trans-
plant Surgeons (ASTS) were invited by e-mail to com-
plete an online survey in which they were provided
clinical scenarios and asked to predict the probability
of death or graft failure (hereafter simply called graft
failure). E-mails were sent in an anonymous fashion
via the ASTS administration. The survey, which is
shown in the supporting information, was designed to
test the following primary hypotheses:
 Hypothesis 1. The variance between surgeons in
estimates of the probability of graft failure would
be high.
 Hypothesis 2. As a group, the surgeon-predicted
graft failure rate for higher risk organs would be
systematically low in comparison with quantita-
tive metrics such as the donor risk index.
Three scenarios were presented. The first 2 scenar-
ios were constructed on the basis of the following
literature evidence. In scenario 1:
 Average-risk recipient: a 53-year-old man with
diabetes and alcoholic cirrhosis complicated by
ascites and encephalopathy who has a Model for
End-Stage Liver Disease (MELD) score of 21.5
 Low-risk donor: a 30-year-old white male with
brain death from a gunshot wound, local share
(donor risk index 1.0, 3-year graft failure risk
21%).1
In scenario 2:
 Average-risk recipient: a 53-year-old man with
diabetes and alcoholic cirrhosis complicated by
ascites and encephalopathy who has a MELD of
score 21.5
 High-risk donor: a 64-year-old black male with
brain death from a stroke, regional share (donor
risk index 2.3, 3-year graft failure risk 40%).1
The order of these scenarios was randomly
alternated in order to test for the phenomenon of
anchoring. We also hypothesized that surgeons would
weigh posttransplant outcomes more heavily than
pretransplant outcomes, and we tested this hypothe-
sis by presenting a third scenario:
 Donor: 64 years old.
 Recipient A: hepatitis C virus cirrhosis and a
MELD score of 32.
or
 Recipient B: Alcoholic cirrhosis and a MELD
score of 17.
Finally, respondents were asked what percentage of
time visual inspection plays a dominant role in the
acceptance decision. Given the anonymous nature of
the survey, we did not know which of the 1029 indi-
viduals in the ASTS database were actively performing
liver transplantation. Therefore, the e-mail requested
participation only from surgeons who were currently
performing liver transplantation. In order to estimate
the response rate among surgeons who were actively
performing liver transplantation, we asked respond-
ents to report their personal liver transplant volume
and compared the sum of the responses to national
data. This study was exempted from oversight by our
institutional review board. Only the clinical character-
istics were provided, not the risk information.
Statistical Analysis
In order to test hypothesis 1, responses of graft failure
estimates were displayed graphically, and the
variance in the responses was compared visually to
that of random chance. Twenty of 201 responses were
outliers and were presumed to reflect inadvertent
surgeon responses to the probability of graft survival
rather than graft failure; those responses were
inverted to graft failure for the primary analyses, and
sensitivity analyses were also performed through the
exclusion of those respondents. In order to test
hypothesis 2, a comparison of the responses and the
literature-derived estimates was performed with the
Kolmogorov-Smirnov test for equality of distribution.
The Student t test was used to determine whether
responses were influenced by the order of the scenar-
ios, and linear regression was used to determine any
association between responses and surgeon charac-
teristics such as transplant volume and time since
the completion of a fellowship.
RESULTS
E-mails were sent to 1029 ASTS members, and com-
plete responses were obtained from 201 individuals
who reported that they were currently performing liver
transplantation. On the basis of the self-reported case
volume, these 201 surgeons were responsible for
6156 of the 6342 liver transplants (97%) performed in
the United States in 2011. The median time since the
completion of a fellowship was 11 years, whereas the
median time was 15 years in the entire ASTS data-
base (P<0.001). Almost 90% of the respondents
(180/201) indicated that the surgeon fielding the offer
was the same one performing transplantation at their
center.
Surgeons’ predictions of the 3-year risk of death or
graft failure varied widely and were systematically low
in comparison with the literature-derived estimates,
as shown in Table 1 and Fig. 1. Figure 1 displays in
histogram format the responses with overlaid normal
distribution curves, and it demonstrates that the vari-
ation in responses approximates what would be
expected by random chance. In scenario 1, 90% of the
respondents provided lower estimates of the graft
failure risk than the literature-derived estimate of
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21%. In scenario 2, 96% of the responses were lower
than the literature-derived estimate of 40%. These dif-
ferences between surgeons’ predictions and literature-
derived estimates were statistically significant
(P<0.001 for both comparisons).
Respondents who received scenario 1 first provided
a mean graft failure estimate of 13.7%, whereas the
mean estimate was 13.8% from those who received
scenario 1 second (P50.9). Respondents who received
scenario 2 second provided a mean estimate of
19.8%, whereas the mean estimate was 23.2% from
those who received scenario 2 first (P50.02). This is
suggestive evidence that the responses to scenario 2
were influenced by the question order and that
surgeons’ decisions about high-risk organs may be
anchored more by their most recent experience than
by their overall experience and published literature. A
sensitivity analysis, in which we excluded subjects
who appeared to have responded with predictions
of graft survival rather than graft failure, did not
change the results (data not shown). None of the
individual variables (years of practice, individual case
volumes, person who fields offers, or opinions regard-
ing visual inspection) were significantly associated
with responses to the clinical scenarios (data not
shown).
In scenario 3, respondents were asked to choose
whether a liver from a 64-year-old donor should go to
(A) a 53-year-old recipient with hepatitis C and a
laboratory MELD score of 32 or (B) a 53-year-old
recipient with alcoholic cirrhosis and a laboratory
MELD score of 17. As shown in Table 2, 74% chose
recipient A, and this suggests that most surgeons
adhere to the spirit of allocation rules by considering
the risk of death on the waiting list more than the pre-
dicted posttransplant outcome.
There was a bimodal distribution of responses
regarding the role of a visual inspection of the donor
liver in the decision to transplant a particular organ,
as shown in Fig. 2. Two-thirds of the respondents
replied that a visual inspection played a critical role
in <40% of cases, whereas one-fifth replied that it
played a critical role in 80% to 100% of cases.
DISCUSSION
This study has demonstrated that liver transplant
surgeons vary widely in their estimates of the proba-
bility of graft failure in specific clinical scenarios.
TABLE 1. Surgeons’ Predictions of the 3-Year Risk of
Graft Failure Versus Estimates from the Literature
Scenario
Median
Response
(%)
Estimate
From
Literature
(%)
P
Value
1. 30-year-old
local white donor
with brain death
from trauma and
average-risk
recipient
15 21 <0.001
2. 64-year-old
regional black
donor with brain
death from a
stroke and
average-risk
recipient
20 40 <0.001
NOTE: The surgeon predictions were systematically low,
particularly for the higher risk scenario.
Figure 1. Surgeons’ predictions of the 3-year risk of death or
graft failure with overlaid normal distribution curves for (A) a
30-year-old local donor and (B) a 64-year-old regional donor.
TABLE 2. Recipient Choices for a Liver From an Older
Donor
Preferred Recipient for a Liver From a
64-Year-Old Donor
Respondents
[n (%)]
53-year-old woman with hepatitis C
virus cirrhosis and a MELD score of 32
149 (74)
53-year-old woman with alcoholic
cirrhosis and a MELD score of 17
52 (26)
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Furthermore, as a group, surgeons made systemati-
cally low estimates of graft failure probability in com-
parison with evidence-based estimates from the
literature, particularly for higher risk organs. These
findings suggest that surgeons are not accurate at
predicting donor-specific risks, and they may provide
a partial explanation for the wide variability in organ
acceptance practices.2,5
These data should not be interpreted as critical of
surgeons but should instead highlight the complexity
of organ offer decisions. Currently, the myriad data
available with an organ offer are evaluated with
mental math and gestalt opinion. Such situations,
particularly when the risks are high, lead to numer-
ous human inconsistencies and biases, which are the
topic of an entire field of study termed behavioral
economics.6 We hypothesize that the availability of a
point-of-care decision aid could improve the consis-
tency and accuracy of organ acceptance decisions and
thus potentially improve patient outcomes. Such a
tool would be intended not to replace clinical judg-
ment but rather to augment it. In fact, the literature
on physician decision support suggests that in many
situations, the judgment of the so-called expert physi-
cians is aided the most.7 We are currently developing
such a tool that estimates the probability of survival
for a given patient by accepting a given organ offer
versus waiting for another one to come along.
The main limitation of this study is the lack of a
true gold standard for expected rates of graft failure.
The scenarios were created to correspond to catego-
ries of the donor risk index, which was derived from
data that are now more than 10 years old. Addition-
ally, some of the variation in the responses may
reflect true differences in outcomes between centers.
Furthermore, because of space constraints and in
order to limit the response burden, the scenarios
lacked many clinical details that would normally
accompany an organ offer. Therefore, these findings
may reflect in part the limitations of currently avail-
able prognostic tools. However, the lack of precision
in the gold standard is unlikely to fully explain the
more than 10-fold variation in risk estimation by
respondents. Finally, none of these limitations can
explain the systematic underestimation of risk by the
respondents.
The choice of a survey study is a second limitation,
in that respondents may have been systematically dif-
ferent from nonrespondents. Although we received
responses from only 201 of 1029 ASTS members, the
most appropriate denominator would have been the
number of ASTS members actively performing liver
transplantation. This number is unknown, although it
is certainly less than the total ASTS membership. The
self-reported personal case volumes of respondents
may be overestimated because there are approxi-
mately 105 liver transplant centers in the United
States and many centers have more than 2 surgeons.
Nonetheless, the case volume calculation does suggest
that the respondents included the majority of
surgeons in the United States actively performing liver
transplantation. Finally, we chose the endpoint of
3-year graft survival because this is most relevant to
donor quality: short-term outcomes are driven largely
by recipient and operative characteristics, whereas
intermediate-term outcomes are significantly influ-
enced by disease recurrence and other factors medi-
ated by donor characteristics.1 Risk factors for 1- and
3-year graft failure are highly correlated, so we feel
that it is unlikely that the findings would have been
different had 1-year graft failure been the primary
outcome.
In summary, transplant surgeons are not accurate
at predicting donor-specific risks. These findings sug-
gest that organ acceptance decisions may be improved
by a point-of-care decision support tool.
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Figure 2. Surgeons’ opinions of the importance of visual inspec-
tion in deciding whether to accept liver allografts.
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